Isracann Biosciences Inc.

CNSX:IPOT Stock Report

Market Cap: CA$2.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Isracann Biosciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Ajay Kaila

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.5yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Ajay Kaila

1.5yrs

Tenure

Ajay Singh Kaila is Interim Chief Executive Officer of Isracann Biosciences Inc. from January 20, 2023.